APOE and Alzheimer disease: The possession of two copies of APOE4 has been shown to not only increase the chance of getting Alzheimer's disease by 12-fold that of a person with two copies of APOE3, but also lower the average age of clinical onset to 68 years of age down from 84 (Corder et al., 1993).